Ajanta Pharma Limited (NSE: AJANTPHARM)

Market Cap	419.97B
Revenue (ttm)	43.33B
Net Income (ttm)	8.54B
Shares Out	125.35M
EPS (ttm)	67.77
PE Ratio	49.44
Forward PE	41.98
Dividend	36.00 (1.07%)
Ex-Dividend Date	n/a

Volume	255,504
Open	3,345.00
Previous Close	3,330.10
Day's Range	3,292.05 - 3,409.40
52-Week Range	1,650.05 - 3,409.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Ajanta Pharma

Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as cardiology, antidiabetic, ophthalmology, dermatology, pain management, and respiratory areas. It also provides tablets, capsules, injectables, inhalers, ointments, creams, and liquids. The company serves in India, Africa, rest of Asia, the United States, and internationally. Ajanta Pharma Limited ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1973
• Employees: 8,073
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AJANTPHARM

Financial Performance

In 2023, Ajanta Pharma's revenue was 42.09 billion, an increase of 12.45% compared to the previous year's 37.43 billion. Earnings were 8.16 billion, an increase of 38.81%.